drugset / Trial / NCT07211425
A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood
NaCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect of multiple oral doses of the strong CYP3A4 inhibitor itraconazole on the pharmacokinetics of a single dose of BI 3031185 following oral administration.
Timeline
- Start
- 2025-10-08
- Primary completion
- 2026-01-21
- Completion
- 2026-01-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3031185 | Unknown | — | Oral |
| Subject | Itraconazole | Small molecule | — | Oral |
Indications
No indication recorded.